BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 185075)

  • 1. MSH stimulates adenylate cyclase and tyrosinase in cultivated melanoma cells in the presence of cytochalasin B.
    DiPasquale A; McGuire J
    Exp Cell Res; 1976 Oct; 102(2):264-8. PubMed ID: 185075
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholera toxin mimics melanocyte stimulating hormone in inducing differentiation in melanoma cells.
    O'Keefe E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2500-4. PubMed ID: 4366771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
    Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
    Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of melanoma tyrosinase by a cyclic AMP-dependent protein kinase in a cell-free system.
    Körner A; Pawelek J
    Nature; 1977 Jun; 267(5610):444-7. PubMed ID: 17836
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
    Fuller BB; Lunsford JB; Iman DS
    J Biol Chem; 1987 Mar; 262(9):4024-33. PubMed ID: 3031058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.
    Slominski A; Moellmann G; Kuklinska E
    J Cell Sci; 1989 Apr; 92 ( Pt 4)():551-9. PubMed ID: 2557357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of pro-opiomelanocortin peptides on cyclic AMP and tyrosinase in melanoma cells.
    Farah JM; Bishop JF; Nguyen HQ; O'Donohue TL
    Peptides; 1986; 7(3):437-41. PubMed ID: 3022251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
    Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
    Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
    Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHrmonal specificity of the melanotropin-sensitive adenylate cyclase of mouse melanoma and effect of cyclic AMP on the tyrosinase activity of mouse melanoma cells, in vitro.
    Lee TH; Lee MS
    Biochim Biophys Acta; 1976 Aug; 444(1):181-91. PubMed ID: 8131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
    Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
    Lee TH; Lee MS
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):663-72. PubMed ID: 402759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of percent labeled mitoses (PLM) analysis to the investigation of melanoma cell responsiveness to MSH stimulation throughout the cell cycle.
    Fuller BB; Brooks BA
    Exp Cell Res; 1980 Mar; 126(1):183-90. PubMed ID: 6766870
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
    Thody AJ; Oliver I; Sherbet GV
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1879-84. PubMed ID: 2851444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
    Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
    Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocyte-stimulating hormone and the regulation of tyrosinase activity in hair follicular melanocytes of the mouse.
    Burchill SA; Thody AJ
    J Endocrinol; 1986 Nov; 111(2):225-32. PubMed ID: 3098884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosinase activity and abundance in Cloudman melanoma cells.
    Halaban R; Pomerantz SH; Marshall S; Lerner AB
    Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of adenylate cyclase by beta-melanotropin in the M2R melanoma cell line.
    Gerst JE; Sole J; Mather JP; Salomon Y
    Mol Cell Endocrinol; 1986 Jul; 46(2):137-47. PubMed ID: 3013705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.
    Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Bregman MD; Hruby VJ; Meyskens FL
    In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.